RootsAnalysis has done a detailed study on Peptides and Macrocycle Drug Discovery:Services and Platforms Market, 2020-2030,covering key aspects of the industry’s evolution and identifying potentialfuture growth opportunities.
Drug discovery is challenging and involves severalcomplexities. In order to continue to add new molecules their pipelines, drugdevelopers are opting to outsource such operations to contract researchorganizations (CROs). Outsourcing of peptides and macrocycle drug discovery hasemerged as one of the recent trends in the overall pharmaceutical domain.
KeyInclusions
· A detailed assessment of the current marketlandscape of companies offering peptide and macrocycle drug discovery services,including developer information (year of establishment, company size andlocation of headquarters), type of peptide manufactured (linear, cyclic,helical and others), drug discovery steps covered in service portfolio (targetvalidation, hit identification, lead generation and lead optimization), peptidegeneration methods used (liquid phase synthesis, solid phase synthesis,microwave-assisted synthesis, recombinant methods and others), peptidemodification services (C-terminal, N-terminal, fret / quenching tags,immunogenic conjugates, linkers / spacers, unnatural AAS, cyclization, stableisotope labels and post-translational modification services) and other servicesoffered (peptide isolation / purification service, peptide detection /identification service and peptide quantification service).
· An insightful geographical benchmarking ofthe capabilities of companies of various sizes, highlighting the key focusareas, comparing their existing strengths both within and beyond theirrespective peer groups (based on geography and company size).
· An in-depth analysis of peptide platform andlibrary service providers, featuring information on their company details (yearof establishment, company size and location of headquarters), purpose of theplatform, type of peptide manufactured (linear, cyclic, helical and others) andplatform access model (pipeline licensing, technology licensing, strategicalliance and library provider).
· Profiles of peptides and macrocycle drugdiscovery service providers, featuring information on the year ofestablishment, location of headquarters, peptide discovery service / platformportfolio, recent developments, and an informed future outlook.
· An analysis of the partnerships that havebeen established in the recent past, covering mergers and acquisitions,research collaborations, R&D agreements, licensing agreements (related toboth technology platforms and service providers) and other form ofcollaborations.
· An analysis of proprietary displaytechnologies developed by different drug discovery technology providers, basedon the 2X2 matrix.
· Informed estimates of the existing marketsize and the future opportunity for peptides and macrocycle drug discoveryservice and platform providers, over the next decade. Based on multipleparameters, such as total pharmaceutical R&D market, biological pipeline,peptide drugs pipeline and drug discovery outsourcing percentage, we haveprovided informed estimates on the evolution of the market for the period2020-2030.
Thereport also features the likely distribution of the current and forecastedopportunity across important market segments, mentioned below:
Typeof peptides
· Synthetic peptides
· Biologic and recombinant peptides
Typeof discovery steps
· Target identification and validation
· Hit identification
· Lead generation
· Lead optimization
TherapeuticArea
· Oncological disorders
· Metabolic disorders
· Cardiovascular disorders
· Infectious diseases
· Urological disorders
· Endocrine disorders
· CNS disorders
· Other diseases
CompanySize
· Small companies
· Mid-sized companies
· Large and very large companies
Keygeographical regions
· Europe
· North America
· Asia-Pacific and the Rest of the World
Formore information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/peptides-and-macrocycle-discovery/300.html
AboutRoots Analysis
RootsAnalysis is one of the fastest growing marketresearch companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
ContactInformation
RootsAnalysis Private Limited
GauravChaudhary
+1(415) 800 3415
